Gain Therapeutics annual free cash flow
2020
2021
2022
2023
2024
Gain Therapeutics Free Cash Flow (FCF) History (GANX)
Gain Therapeutics reported −$18.9M in free cash flow for fiscal 2024, a decrease of $15,089 from the previous fiscal year.
View full Gain Therapeutics company overviewGain Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$18.9M | −$15,089 | — | — |
| 2023 | 2023-12-31 | −$18.9M | −$4.1M | — | −34217.53% |
| 2022 | 2022-12-31 | −$14.8M | −$2.4M | — | −11166.38% |
| 2021 | 2021-12-31 | −$12.5M | −$9.2M | — | −9303.42% |
| 2020 | 2020-12-31 | −$3.3M | — | — | −11291.38% |
Gain Therapeutics quarterly free cash flow
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$6.1M | −$1.8M | — | — |
| Q4 2023 | 2023-12-31 | −$5.7M | −$1.7M | — | — |
| Q3 2023 | 2023-09-30 | −$4.0M | −$621,110 | — | — |
| Q2 2023 | 2023-06-30 | −$5.0M | $70,602 | — | — |
| Q1 2023 | 2023-03-31 | −$4.2M | −$1.8M | — | −7663.03% |
| Q4 2022 | 2022-12-31 | −$3.9M | $243,452 | — | — |
| Q3 2022 | 2022-09-30 | −$3.3M | −$1.1M | — | −3518.60% |
| Q2 2022 | 2022-06-30 | −$5.1M | −$1.9M | — | −5358.05% |
| Q1 2022 | 2022-03-31 | −$2.5M | $383,179 | — | −6540.61% |
| Q4 2021 | 2021-12-31 | −$4.2M | −$2.8M | — | −13380.53% |
| Q3 2021 | 2021-09-30 | −$2.2M | −$1.5M | — | −13928.13% |
| Q2 2021 | 2021-06-30 | −$3.2M | −$2.8M | — | −3969.23% |
| Q1 2021 | 2021-03-31 | −$2.8M | −$2.1M | — | −53869.71% |
| Q4 2020 | 2020-12-31 | −$1.3M | — | — | −14473.88% |
| Q3 2020 | 2020-09-30 | −$756,434 | — | — | −11296.80% |
| Q2 2020 | 2020-06-30 | −$424,224 | — | — | −6656.58% |
| Q1 2020 | 2020-03-31 | −$757,713 | — | — | −11354.91% |
Gain Therapeutics free cash flow growth trends
Gain Therapeutics's latest reported quarter, Q3 2024, generated −$6.1M in free cash flow, a decrease of $1.8M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Gain Therapeutics filings at SEC.gov ↗